BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16411527)

  • 1. Influence of icodextrin on plasma and dialysate levels of N(epsilon)-(carboxymethyl)lysine and N(epsilon)-(carboxyethyl)lysine.
    Konings CJ; Schalkwijk CG; van der Sande FM; Leunissen KM; Kooman JP
    Perit Dial Int; 2005; 25(6):591-5. PubMed ID: 16411527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "NEPP" peritoneal dialysis regimen has beneficial effects on plasma CEL and 3-DG, but not pentosidine, CML, and MGO.
    le Poole CY; van Ittersum FJ; Valentijn RM; Teerlink T; Lindholm B; Ter Wee PM; Schalkwijk CG
    Perit Dial Int; 2012; 32(1):45-54. PubMed ID: 21632443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of Nepsilon-(carboxymethyl)lysine and Nepsilon-(carboxyethyl)lysine in human plasma protein by stable-isotope-dilution tandem mass spectrometry.
    Teerlink T; Barto R; Ten Brink HJ; Schalkwijk CG
    Clin Chem; 2004 Jul; 50(7):1222-8. PubMed ID: 15131022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dwell time on carbonyl stress using icodextrin and amino acid peritoneal dialysis fluids.
    Ueda Y; Miyata T; Goffin E; Yoshino A; Inagi R; Ishibashi Y; Izuhara Y; Saito A; Kurokawa K; Van Ypersele De Strihou C
    Kidney Int; 2000 Dec; 58(6):2518-24. PubMed ID: 11115086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of bicarbonate/lactate-buffered PD fluids on N{ε}-(carboxyethyl)lysine and N{ε}-(carboxymethyl)lysine in peritoneal effluent.
    Cnossen TT; Gladziwa U; van de Kerkhof JJ; Schalkwijk CG; Scheijen J; van Amersfoort J; Moret K; Beerenhout CH; Kooman JP
    Perit Dial Int; 2011; 31(2):189-93. PubMed ID: 20671103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A preceding exchange with polyglucose versus glucose solution modifies peritoneal equilibration test results.
    Lilaj T; Dittrich E; Puttinger H; Schneider B; Haag-Weber M; Hörl WH; Vychytil A
    Am J Kidney Dis; 2001 Jul; 38(1):118-26. PubMed ID: 11431191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraperitoneal IL-6 signaling in incident patients treated with icodextrin and glucose bicarbonate/lactate-based peritoneal dialysis solutions.
    Opatrna S; Lysak D; Trefil L; Parker C; Topley N
    Perit Dial Int; 2012; 32(1):37-44. PubMed ID: 22302924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amadori albumin and advanced glycation end-product formation in peritoneal dialysis using icodextrin.
    Posthuma N; ter Wee PM; Niessen H; Donker AJ; Verbrugh HA; Schalkwijk CG
    Perit Dial Int; 2001; 21(1):43-51. PubMed ID: 11280495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritoneal accumulation of advanced glycosylation end-products in diabetic rats on dialysis with icodextrin.
    Lee JH; Reddy DK; Saran R; Moore HL; Twardowski ZJ; Nolph KD; Khanna R
    Perit Dial Int; 2000; 20 Suppl 5():S39-47. PubMed ID: 11229611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Icodextrin metabolism and alpha-amylase activity in nonuremic rats undergoing chronic peritoneal dialysis.
    García-López E; Pawlaczyk K; Anderstam B; Qureshi AR; Kuzlan-Pawlaczyk M; Heimbürger O; Werynski A; Lindholm B
    Perit Dial Int; 2007; 27(4):415-23. PubMed ID: 17602150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous Determination of N
    Gong RZ; Wang YH; Wang YF; Chen B; Gao K; Sun YS
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30558131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irbesartan treatment does not influence plasma levels of the advanced glycation end products N(epsilon)(1-carboxymethyl)lysine and N(epsilon)(1-carboxyethyl)lysine in patients with type 2 diabetes and microalbuminuria. A randomized controlled trial.
    Engelen L; Persson F; Ferreira I; Rossing P; Hovind P; Teerlink T; Stehouwer CD; Parving HH; Schalkwijk CG
    Nephrol Dial Transplant; 2011 Nov; 26(11):3573-7. PubMed ID: 21385863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nepsilon-(carboxymethyl)lysine, Nepsilon-(carboxyethyl)lysine and vascular cell adhesion molecule-1 (VCAM-1) in relation to peritoneal glucose prescription and residual renal function; a study in peritoneal dialysis patients.
    van de Kerkhof J; Schalkwijk CG; Konings CJ; Cheriex EC; van der Sande FM; Scheffer PG; ter Wee PM; Leunissen KM; Kooman JP
    Nephrol Dial Transplant; 2004 Apr; 19(4):910-6. PubMed ID: 15031349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous analysis of N(ε) -(carboxymethyl)Lysine and N(ε) -(carboxyethyl)lysine in foods by ultra-performance liquid chromatography-mass spectrometry with derivatization by 9-fluorenylmethyl chloroformate.
    Zhou Y; Lin Q; Jin C; Cheng L; Zheng X; Dai M; Zhang Y
    J Food Sci; 2015 Feb; 80(2):C207-17. PubMed ID: 25559609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The increase in plasma levels of Nepsilon-(carboxymethyl)lysine during icodextrin treatment of peritoneal dialysis patients is not associated with increased plasma levels of vascular cell adhesion molecule-1.
    Kooman JP; Schalkwijk CG; Konings CJ
    Perit Dial Int; 2006; 26(3):410-1. PubMed ID: 16722038
    [No Abstract]   [Full Text] [Related]  

  • 16. Free L-Lysine and Its Methyl Ester React with Glyoxal and Methylglyoxal in Phosphate Buffer (100 mM, pH 7.4) to Form
    Baskal S; Tsikas D
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technical note. The serum concentration of the advanced glycation end-product N epsilon-(carboxymethyl)lysine is increased in uremia.
    Degenhardt TP; Grass L; Reddy S; Thorpe SR; Diamandis EP; Baynes JW
    Kidney Int; 1997 Oct; 52(4):1064-7. PubMed ID: 9328946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of non enzymatic glycosylation in vivo: impact of different dialysis solutions.
    Ho-dac-Pannekeet MM; Weiss MF; de Waart DR; Erhard P; Hiralall JK; Krediet RT
    Perit Dial Int; 1999; 19 Suppl 2():S68-74. PubMed ID: 10406497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal transport characteristics with glucose polymer based dialysate.
    Ho-dac-Pannekeet MM; Schouten N; Langendijk MJ; Hiralall JK; de Waart DR; Struijk DG; Krediet RT
    Kidney Int; 1996 Sep; 50(3):979-86. PubMed ID: 8872974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Icodextrin degradation products in spent dialysate of CAPD patients and the rat, and its relation with dialysate osmolality.
    de Waart DR; Zweers MM; Struijk DG; Krediet RT
    Perit Dial Int; 2001; 21(3):269-74. PubMed ID: 11475342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.